AVMBioMed is a contract research organization (CRO) specializing in the novel discovery of post-translational modifications (PTM). Our Snapshot Proteomics™ technology uses protein microarrays to capture PTM from complex mixtures like cell extracts and patient samples, identifies specific protein-protein interactions, and reveals novel enzyme-substrate pairings. Our services provide powerful and novel information for basic science, target validation, preclinical compound characterization and biomarker discovery. Explore our site to learn more about our services and technology, and then contact us to discuss your project or idea.
Snapshot Proteomics™, a more complete picture of biology.
Genomic testing and sequencing technologies are currently changing clinical practice, but proteomics has an even greater potential to empower truly personalized medicine. In comparison to other approaches, our technology is conceptually straightforward, and far more informative and reproducible than traditional proteomic techniques. We use microarrays containing ~20,000 human proteins to provide the clearest and most complete picture of the active proteome.